Oral Solid Dose CDMOs

Solventum

China

Solventum (spun off from 3M) is a healthcare company whose Purification and Filtration business provided biopharmaceutical purification solutions including chromatography media, filtration membranes, and purification systems. This business unit has been acquired by Thermo Fisher Scientific. Solventum supplied equipment and consumables for bioprocessing, not contract drug manufacturing.

SteriMax Inc.

Canada

SteriMax Inc. is a family-owned Canadian specialty pharmaceutical company based in Oakville, Ontario. They develop, source, manufacture, market, and distribute essential hospital and retail pharmacy products to the Canadian healthcare market. Their portfolio includes generic and branded products across sterile injectables, oral solids, and other essential products. SteriMax has a Health Canada-approved QC lab and their products are manufactured in Health Canada, FDA, or EMEA approved facilities. While they have some internal pharmaceutical manufacturing capabilities (their website mentions production and manufacturing), their primary model appears to be sourcing, marketing, and distributing pharmaceutical products in Canada rather than offering contract manufacturing services to third parties. They are not positioned as a CDMO/CMO.

Sumitomo (SHI) Demag

Germany

Sumitomo (SHI) Demag Plastics Machinery GmbH manufactures injection moulding machines (all-electric, hydraulic, and hybrid types) for the plastics industry with over 125,000 machines installed globally. While the company serves pharmaceutical packaging and medical device applications, it does not manufacture drugs or pharmaceutical products.

CMP Phar.ma Srl

Italy

CMP Phar.ma Srl is an Italian manufacturer of inspection and leak test machines for pharmaceutical parenteral products, operating since 1969. The company produces optical inspection benches, semi-automatic and fully automatic inspection machines, and leak test systems for ampoules, vials, cartridges, and prefilled syringes, with ISO 9001 certification since 2008. CMP Phar.ma is part of the Marchesini Group.

Eumedica Pharmaceuticals

Belgium

Eumedica Pharmaceuticals is a Belgian pharmaceutical distribution and logistics company operating since 1986, providing warehousing, value-added logistics services, secondary packaging, serialization, and regulatory affairs for multinational pharmaceutical companies. It distributes pharmaceutical products but does not manufacture drugs under contract for others.

Laboratorios LAM

Dominican Republic

Laboratorios LAM is a Dominican Republic-based pharmaceutical company that manufactures and markets a large portfolio of generic medicines across multiple therapeutic areas including cardiology, neurology, oncology, gastroenterology, anti-infectives, urology, psychiatry, and pediatrics. They have a modern GMP production plant with advanced technology. Their product list includes over 200 generic medicines in various oral solid and liquid forms. While they have their own manufacturing plant, they primarily manufacture their own branded generics for the Dominican Republic and regional markets rather than offering contract manufacturing services to third parties.

Recce Pharmaceuticals

Australia

Recce Pharmaceuticals (ASX:RCE) is a clinical-stage biotech company developing its own proprietary synthetic anti-infectives (RECCE 327, RECCE 529) for antibiotic-resistant bacterial and viral infections. They have an in-house pilot manufacturing facility in Macquarie Park, Sydney for their own compounds only -- they are NOT a contract manufacturer (CDMO/CMO). They conduct clinical trials (Phase I-III) for their own drug pipeline. The FDA registration data and approved products listed in the regulatory summary likely belong to a different entity sharing the FEI numbers, not this clinical-stage company.

Upsher-Smith Laboratories

United States

Upsher-Smith Laboratories is a U.S. pharmaceutical company (now a subsidiary of Bora Pharmaceuticals following a $210 million acquisition in April 2024) that manufactures and markets brand and generic pharmaceutical products. It has a 270,000 sq ft manufacturing facility in Plymouth/Maple Grove, Minnesota. Key products include branded medications for migraine and seizure disorders plus a wide variety of generics (48 products). In December 2025 it launched KYMBEE (deflazacort) for Duchenne muscular dystrophy. While Bora Pharmaceuticals is a CDMO, Upsher-Smith itself manufactures and markets its own branded/generic portfolio rather than providing contract manufacturing services to third parties.

Jiangsu Hengrui Medicine Co., Ltd. is China's largest listed pharmaceutical company, founded in 1970, with over 20,000 employees globally. Hengrui is primarily an innovation-driven pharma company developing and manufacturing its own drugs across oncology, cardiovascular, metabolism, autoimmune, pain, and anti-infection therapeutic areas, with a pipeline of 257 drugs and 24 Class 1 innovative drugs. While it has some CDMO references in search results, Perplexity research confirms it primarily specializes in proprietary drug development and manufacturing rather than contract services.

Sun Pharmaceutical Industries Ltd. (Sun Pharma) is one of the world's largest specialty generic pharmaceutical companies, headquartered in Mumbai, India. While the company has massive manufacturing operations (1,075 FDA-approved products, 25+ FDA-registered FEI numbers), it primarily manufactures and markets its own branded and generic pharmaceutical products rather than providing contract manufacturing services to third parties as a CDMO.

Hoffmann Neopac AG is a leading packaging manufacturer of Polyfoil, PE, and COEX tubes for pharmaceutical, cosmetics, and dental industries with over 100 years of history. The company operates production sites in Switzerland (450 million tubes/year), Hungary, the US, and India, with combined global capacity exceeding 1 billion tubes per year. Neopac is ISO 15378 (pharmaceutical packaging) certified but does not manufacture drugs.

Yung Shin Pharmaceutical Industrial Co., Ltd. (YSP) is a Taiwanese pharmaceutical company founded in 1952, manufacturing prescription medications, OTC medicines, health food, and cosmetics. The company exports to 35+ countries and has passed US FDA and Japan PMDA inspections. Primarily manufactures and markets its own branded pharmaceutical products.